ID.1
Item
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
boolean
ID.2
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
boolean
ID.3
Item
while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
boolean
ID.4
Item
eastern cooperative oncology group performance status 0-2.
boolean
ID.5
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
ID.6
Item
prior acupuncture within one year of enrollment.
boolean
ID.7
Item
known metastatic (stage iv) breast or colorectal cancer involvement.
boolean
ID.8
Item
pre-existing peripheral neuropathy before chemotherapy is initiated
boolean
ID.9
Item
currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
boolean